According to the statements of the pharmaceutical company called Eli Lilly and Co, the combined antibody treatment developed by the company reduces hospitalizations and mortality (death) due to covid-19 by 87%.
According to the statements of the pharmaceutical company called Eli Lilly and Co, the combined antibody treatment developed by the company reduces hospitalizations and mortality (death) due to covid-19 by 87%.